BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 17695414)

  • 1. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
    Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
    Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome.
    Magri V; Trinchieri A; Ceriani I; Marras E; Perletti G
    Arch Ital Urol Androl; 2007 Jun; 79(2):93-8. PubMed ID: 17695415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.
    Magri V; Marras E; Restelli A; Wagenlehner FM; Perletti G
    Exp Ther Med; 2015 Mar; 9(3):658-666. PubMed ID: 25667610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
    Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
    Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: can the change in prostate-specific antigen reliably guide prostate biopsy decisions?
    Torky M; Mosharafa A; Emran A; Kamal A; Abdelhamid M
    Urol Int; 2011; 87(4):416-9. PubMed ID: 21934292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10 ng/mL?
    Busato WF; Almeida GL; Geraldo J; Busato FS
    Int Braz J Urol; 2015; 41(2):329-36. PubMed ID: 26005976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Asymptomatic prostatitis: a frequent cause of raising PSA].
    Terrone C; Poggio M; Bollito E; Cracco CM; Scarpa RM
    Recenti Prog Med; 2005; 96(7-8):365-9. PubMed ID: 16209120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
    Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
    Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
    J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study.
    Morgia G; Cimino S; Favilla V; Russo GI; Squadrito F; Mucciardi G; Masieri L; Minutoli L; Grosso G; Castelli T
    Int Braz J Urol; 2013; 39(2):214-21. PubMed ID: 23683667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients.
    Serretta V; Catanese A; Daricello G; Liotta R; Allegro R; Martorana A; Aragona F; Melloni D
    Prostate Cancer Prostatic Dis; 2008; 11(2):148-52. PubMed ID: 17637759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml.
    Kaygisiz O; Uğurlu O; Koşan M; Inal G; Oztürk B; Cetinkaya M
    Prostate Cancer Prostatic Dis; 2006; 9(3):235-8. PubMed ID: 16718277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
    Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
    Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies?
    Erol H; Beder N; Calişkan T; Dündar M; Unsal A; Culhaci N
    Urol Int; 2006; 76(1):20-6. PubMed ID: 16401916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome.
    Nadler RB; Collins MM; Propert KJ; Mikolajczyk SD; Knauss JS; Landis JR; Fowler JE; Schaeffer AJ; Alexander RB;
    Urology; 2006 Feb; 67(2):337-42. PubMed ID: 16442595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of antibiotics on elevated serum prostate specific antigen in patients with urinary symptoms and negative digital rectal examination: a pilot study.
    Bulbul MA; Wazzan W; Hijaz A; Shaar A
    J Med Liban; 2002; 50(1-2):23-5. PubMed ID: 12841309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.